市場調查報告書
商品編碼
1470837
雷射捕捉晶粒市場:按產品、技術、應用和最終用戶分類 - 2024-2030 年全球預測Laser Capture Microdissection Market by Product (Consumables, Instruments, Software & Services), Technique (Immune Laser Capture, Infrared Laser Microdissection, UV Laser Microdissection), Application, End-user - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年雷射捕獲晶粒市場規模為1.6594億美元,2024年達1.7614億美元,2030年達2.572億美元,複合年成長率為6.46%。
雷射捕捉晶粒(LCM) 是一種準確有效的技術,用於從各種組織樣本中獲取特定細胞群,使研究人員能夠分離分離的細胞或詳細研究特定的組織學區域。 LCM 技術的不斷改進,例如提高雷射精度和自動化,透過提高各個研究領域的效率和適用性,顯著促進了市場成長。了解和治療癌症等慢性疾病的需求不斷成長,推動了研究和診斷中對 LCM 的需求,從而推動了市場成長。向個人化醫療的轉變和對生物標記發現的重視將進一步增加對 LCM 的需求,因為它對於分析細胞層面的疾病機制至關重要。然而,需要專門的培訓來操作 LCM 設備並分析所得樣本,這可能會對雷射捕獲晶粒的採用構成障礙。組織製備方法會影響 LCM 解剖樣本的質量,限制下游分子分析的可靠性,並對市場擴張構成挑戰。此外,開拓與下游分子分析平台無縫整合的全自動LCM系統將顯著提高效率和準確性,創造市場成長潛力。專注於使 LCM 變得更實惠、更容易獲得的研究,尤其是在新興市場,可能會在未來幾年推動更廣泛的採用並刺激市場擴張。
主要市場統計 | |
---|---|
基準年[2023] | 16594萬美元 |
預測年份 [2024] | 17614萬美元 |
預測年份 [2030] | 2.572 億美元 |
複合年成長率(%) | 6.46% |
產品擴大採用雷射捕獲晶粒儀器,因為它們能夠高精度地分離特定細胞以進行詳細的分子分析
耗材是 LCM 流程的重要組成部分,可確保從樣本採集到下游分析流程都能維持樣本的完整性和品質。專為 LCM 應用設計的檢測套件、試劑和介質可提供成功晶粒所需的精確度。這些耗材確保分離細胞的生化特性得以維持,以進行進一步的分子分析。 LCM 技術儀器是先進的設備,將雷射光學的精度與軟體結合,以精確定位並從組織切片中分離特定的細胞群。這些設備的複雜性和功能各不相同,有些設備包括可提高準確性和效率的自動化功能。區分這些設備的主要因素包括所使用的雷射類型、控制機構的精度、自動化程度以及與下游分析工具的整合。軟體和服務是補充 LCM 技術物理方面的關鍵組件。該軟體解決方案旨在增強 LCM 儀器的功能,為使用者提供直覺的介面,用於設計實驗、控制雷射捕獲過程和分析結果資料。這些軟體平台通常包括影像分析、組織圖譜以及與基因組或蛋白質體分析工具的整合等功能。服務還包括培訓、技術支援和維護,以幫助使用者充分發揮 LCM 技術的潛力。
應用:擴大診斷應用,直接從組織分離患病細胞,並實現疾病標記的檢測和分析。
在細胞生物學中,LCM 透過允許在複雜的組織環境中精確選擇單一細胞或細胞群來幫助研究細胞功能、相互作用和途徑。透過 LCM,科學家分離特定的細胞類型以進行下游分析,例如 RNA、DNA 和蛋白質表現。這使得我們能夠更精確地了解細胞行為、細胞層面的疾病機制以及藥物對特定細胞類型的影響。 LCM 能夠精確檢測和分析疾病標記。這種能力在癌症診斷中很有價值,區分良性和惡性細胞並識別特定突變非常重要。 LCM 允許法醫學專家從多個來源的細胞混合物中選擇性地分離和分析特定個體的細胞。這種準確性提高了法醫學調查中 DNA 分析的可靠性,並為解決複雜案件做出了巨大貢獻。在分子生物學中,LCM 用於在分子層面上解剖複雜的組織。 LCM 能夠詳細研究特定細胞內的基因表現、蛋白質-蛋白質交互作用和分子途徑。 LCM 在推動個人化醫療方面發揮著至關重要的作用,個人化醫療可以根據每位患者的特徵量身定做治療方法。透過從患者組織樣本中分離特定細胞,LCM 能夠對疾病病理學進行詳細的分子分析,並幫助識別疾病感受性、預後和治療反應的生物標記。在研究和開發中,LCM 有助於藥物和治療標靶的發現和檢驗。它支持對複雜組織環境中特定細胞的詳細分析,有助於了解疾病機制、識別新藥物標靶以及評估藥物療效和毒性。
區域洞察
在美洲地區,由於在研發方面的大量投資、強大的生物技術和醫學研究框架,美國在 LCM 技術的採用和開發方面處於領先地位。美國的需求主要由其強大的學術和研究機構以及製藥和生物技術行業創新的持續推動。歐洲、中東和非洲地區在 LCM 技術的採用和開發方面呈現出多樣化的景象。 LCM 在歐洲的採用主要是由先進的醫療保健系統、強大的研究機構以及對癌症研究和分子診斷的堅定承諾所推動的。在醫療基礎設施快速發展、研發興趣不斷增強的中東地區,人們對包括 LCM 在內的先進診斷和研究技術的興趣也在增加。非洲地區的市場成長主要是由與專注於解決感染疾病和癌症等特定健康挑戰的國際組織和資助機構的合作所推動的。在擴大研究基礎設施以及增加生物技術和醫療保健的政府和私人資金的推動下,亞太地區的 LCM 市場正在快速成長。中國對 LCM 等先進技術的需求正在迅速成長,中國正在大力投資醫療改革和生物醫學研究。日本和印度由於生命科學領域先進的研究環境和政府的大力支持,LCM 的採用率很高。
FPNV定位矩陣
FPNV 定位矩陣對於評估雷射捕獲晶粒市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對雷射捕獲晶粒市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.雷射捕獲晶粒市場的市場規模和預測是多少?
2.在雷射捕捉晶粒市場的預測期內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.雷射捕捉晶粒市場的技術趨勢和法規結構是什麼?
4.雷射捕獲晶粒市場主要供應商的市場佔有率是多少?
5. 進入雷射捕獲晶粒市場的合適型態和策略手段是什麼?
[196 Pages Report] The Laser Capture Microdissection Market size was estimated at USD 165.94 million in 2023 and expected to reach USD 176.14 million in 2024, at a CAGR 6.46% to reach USD 257.20 million by 2030.
Laser Capture Microdissection (LCM) is a precise and efficient technique for obtaining specific cell populations from various tissue samples, enabling researchers to study isolated cells and specific histological regions in detail. Continuous improvements in LCM technology, such as enhanced laser precision and automation, significantly drive market growth by increasing efficiency and applicability in various research domains. The increasing need for understanding and treating chronic diseases such as cancer fuels the demand for LCM in research and diagnostics, thereby propelling market growth. The shift towards personalized medicine and the emphasis on biomarker discovery further augment the demand for LCM, as it is crucial in analyzing disease mechanisms at the cellular level. However, the requirement for specialized training to operate LCM equipment and analyze obtained samples may create barriers to the adoption of laser capture microdissection. Tissue preparation methods can impact the quality of the samples dissected via LCM, potentially limiting the reliability of downstream molecular analyses and challenging market expansion. Moreover, developing fully automated LCM systems that seamlessly integrate with downstream molecular analysis platforms could significantly enhance efficiency and accuracy, creating growth potential in the market. Research focused on making LCM more affordable and accessible, especially in emerging markets, could catalyze broader adoption and spur market expansion in upcoming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 165.94 million |
Estimated Year [2024] | USD 176.14 million |
Forecast Year [2030] | USD 257.20 million |
CAGR (%) | 6.46% |
Product: Increasing adoption of laser capture microdissection instruments owing to their precision in isolating specific cells for detailed molecular analysis
Consumables form an essential part of the LCM process, ensuring the integrity and quality of samples are maintained throughout the capture and downstream analysis process. Assay kits, reagents, and media explicitly designed for LCM applications offer the precision required for successful microdissection. These consumables ensure that the biochemical properties of the isolated cells are preserved for further molecular analysis. Instruments in LCM technology are sophisticated devices that combine the precision of laser optics with software to accurately target and isolate specific cell populations from a tissue section. These instruments vary in their complexity and capabilities, with some offering automated features to enhance precision and efficiency. Key factors that distinguish these instruments include the different type of laser used, the precision of the control mechanisms, the level of automation, and the integration with downstream analysis tools. Software and services are critical components that complement the physical aspects of LCM technology. Software solutions have been designed to enhance the functionality of LCM instruments, providing users with intuitive interfaces to design experiments, control the laser capture process, and analyze the data obtained. These software platforms often include features for image analysis, tissue mapping, and integration with genomic or proteomic analysis tools. Services may include training, technical support, and maintenance, ensuring that users maximize the potential of their LCM technology.
Application: Widening application in diagnostics to isolate diseased cells directly from tissues, enabling the detection and analysis of disease markers
In cell biology, LCM aids in the study of cellular functions, interactions, and pathways by allowing for the precise selection of individual cells or groups of cells from within a complex tissue environment. Through LCM, scientists isolate specific cell types for downstream analyses, such as RNA, DNA, and protein expressions. This enables a more accurate understanding of cellular behavior, disease mechanisms at the cellular level, and the drug's effect on specific cell types. LCM enables the detection and analysis of disease markers at a precise level. This capability is valuable in cancer diagnostics, where differentiating between benign and malignant cells and identifying specific mutations is critical. LCM allows forensic experts to selectively isolate and analyze cells from specific individuals in a mixture of cells from multiple sources. This precision improves the reliability of DNA profiling in forensic investigations, contributing significantly to the resolution of complex cases. In molecular biology, LCM is used to dissect the complexity of tissues at the molecular level. LCM allows detailed study of gene expression, protein-protein interactions, and molecular pathways within specific cells. LCM plays a pivotal role in advancing personalized medicine, where treatments are customized to the individual characteristics of each patient. By isolating specific cells from patients' tissue samples, LCM enables the detailed molecular analysis of disease pathology, helping identify biomarkers for disease susceptibility, prognosis, and response to treatment. In research & development, LCM is instrumental in discovering and validating pharmaceutical and therapeutic targets. It supports the detailed analysis of specific cells within a complex tissue environment, aiding in understanding disease mechanisms, identifying novel drug targets, and assessing drug efficacy and toxicity.
Regional Insights
In the Americas region, the United States leads in the adoption and development of LCM technologies, driven by substantial investments in R&D, a robust biotechnology, and medical research framework. The demand in the U.S. is primarily driven by its strong academic and research institutions, alongside the pharmaceutical and biotech industries' constant push for innovation. The EMEA region shows a diverse landscape in the adoption and development of LCM technologies. LCM adoption in Europe is primarily driven by advanced healthcare systems, robust research institutions, and a keen focus on cancer research and molecular diagnostics. The Middle East, with its rapidly developing healthcare infrastructure and rising focus on research and development, shows a growing interest in advanced diagnostic and research technologies, including LCM. Market growth in Africa's region is primarily driven by collaborations with international institutions and funding bodies focused on addressing specific health challenges, including infectious diseases and cancer. The Asia Pacific region is witnessing a rapid growth in the LCM market, propelled by expanding research infrastructure and increasing government and private funding in biotechnology and healthcare. China, with its significant investments in healthcare reforms and biomedical research, exhibits a burgeoning demand for advanced technologies such as LCM. Japan and India shows a high adoption rate of LCM driven by its advanced research landscape in life sciences and strong governmental support.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Laser Capture Microdissection Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Laser Capture Microdissection Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Laser Capture Microdissection Market, highlighting leading vendors and their innovative profiles. These include 3DHISTECH Ltd., Agilent Technologies, Inc., AnaPath Services GmbH, Bio-Rad Laboratories, Inc., CaresBio Laboratory, Carl Zeiss AG, Crown Bioscience, Danaher Corporation, DeNova Sciences, DSS Imagetech Pvt. Ltd., Epistem Ltd., F. Hoffmann-La Roche AG, GE HealthCare, Gnome Diagnostics, LLC, HUBNER Group, Molecular Machines & Industries GmbH, Ocimum Biosolutions, Standard BioTools Inc., Thermo Fisher Scientific Inc., and VitroVivo Biotech LLC.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Laser Capture Microdissection Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Laser Capture Microdissection Market?
3. What are the technology trends and regulatory frameworks in the Laser Capture Microdissection Market?
4. What is the market share of the leading vendors in the Laser Capture Microdissection Market?
5. Which modes and strategic moves are suitable for entering the Laser Capture Microdissection Market?